Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023

Table of Contents

1 INTRODUCTION 26

1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.2.1 MARKETS COVERED 27
1.2.2 YEARS CONSIDERED FOR THE STUDY 28
1.3 CURRENCY 29
1.4 LIMITATIONS 29
1.5 STAKEHOLDERS 29

2 RESEARCH METHODOLOGY 30

2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
2.2 MARKET SIZE ESTIMATION 36
2.2.1 BOTTOM-UP APPROACH 37
2.2.2 TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
2.4 ASSUMPTIONS FOR THE STUDY 39

3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 47

4.1 BIOSURGERY MARKET: OVERVIEW 47
4.2 APAC: BIOSURGERY MARKET, BY TYPE & COUNTRY (2017) 48
4.3 GEOGRAPHIC SNAPSHOT OF THE BIOSURGERY MARKET (2017) 49
4.4 GEOGRAPHIC MIX: BIOSURGERY MARKET, 2016 — 2023 (USD MILLION) 50
4.5 BIOSUGERY MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2018 VS. 2023 (USD MILLION) 50

5 MARKET OVERVIEW 51

5.1 INTRODUCTION 51
5.2 DRIVERS 52
5.2.1 RISING GERIATRIC POPULATION 52
5.2.2 INCREASING VOLUME OF SURGERIES AND PREVALENCE OF SEVERE TRAUMA INJURIES 52
5.2.3 STRONG FOCUS ON R&D LEADING TO THE LAUNCH OF NEW AND ADVANCED PRODUCTS 54
5.2.4 RISING NEED FOR EFFECTIVE BLOOD LOSS MANAGEMENT IN PATIENTS 54
5.3 MARKET RESTRAINTS 55
5.3.1 HIGH PRICE OF BIOSURGERY PRODUCTS & RISING COST OF SURGICAL PROCEDURES 55
5.4 MARKET OPPORTUNITIES 55
5.4.1 UNTAPPED EMERGING MARKETS 55
5.5 MARKET CHALLENGES 56
5.5.1 STRINGENT REGULATORY FRAMEWORK 56
5.5.2 REQUIREMENT OF SKILLED PERSONNEL FOR THE EFFECTIVE USE OF BIOSURGERY PRODUCTS 56

6 INDUSTRY INSIGHTS 57

6.1 INDUSTRY TRENDS 57
6.1.1 INCREASING MARKET CONSOLIDATION 57
6.1.2 RISING FOCUS ON PRODUCT DEVELOPMENTS & LAUNCHES 58
6.1.3 GROWING DEMAND FOR DENTAL BONE-GRAFT SUBSTITUTES 59
6.1.4 GROWING PREFERENCE FOR GELATIN-BASED ADHESIVES & HYDROGELS IN SURGICAL PROCEDURES 60
6.2 REGULATORY ANALYSIS 61
6.2.1 NORTH AMERICA 62
6.2.1.1 US 62
6.2.1.2 Canada 64
6.2.2 EUROPE 65
6.2.3 APAC 65
6.2.3.1 Japan 65
6.2.3.2 China 66
6.2.3.3 India 67
6.3 STRATEGIC BENCHMARKING 67
6.3.1 BIOSURGERY MARKET: PRODUCT PORTFOLIO ANALYSIS 68
6.3.2 NATURAL/BIOLOGICAL SEALANTS & ADHESIVES: PRODUCT PORTFOLIO ANALYSIS 69
6.3.3 SYNTHETIC & SEMISYNTHETIC SEALANTS & ADHESIVES: PRODUCT PORTFOLIO ANALYSIS 70
6.3.4 HEMOSTATIC AGENTS: PRODUCT PORTFOLIO ANALYSIS 70
6.3.5 ADHESION BARRIERS: PRODUCT PORTFOLIO ANALYSIS 71
6.3.6 SOFT-TISSUE ATTACHMENTS: PRODUCT PORTFOLIO ANALYSIS 72
6.3.7 BONE-GRAFT SUBSTITUTES : PRODUCT PORTFOLIO ANALYSIS 73

7 BIOSURGERY MARKET, BY PRODUCT 74

7.1 INTRODUCTION 75
7.2 BONE-GRAFT SUBSTITUTES 76
7.2.1 DEMINERALIZED BONE MATRIX 78
7.2.2 SYNTHETIC BONE GRAFTS 80
7.2.3 BONE MORPHOGENETIC PROTEINS 82
7.2.4 OTHER BONE-GRAFT SUBSTITUTES 84
7.3 SOFT-TISSUE ATTACHMENTS 85
7.3.1 SYNTHETIC MESHES 87
7.3.2 BIOLOGICAL MESHES 89
7.3.2.1 Allografts 91
7.3.2.2 Xenografts 92
7.4 HEMOSTATIC AGENTS 93
7.4.1 THROMBIN-BASED HEMOSTATIC AGENTS 94
7.4.2 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS 96
7.4.3 COMBINATION HEMOSTATIC AGENTS 97
7.5 SURGICAL SEALANTS AND ADHESIVES 98
7.5.1 NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES 100
7.5.1.1 Natural/Biological sealants and adhesives, by type 100
7.5.1.1.1 Fibrin sealants 101
7.5.1.1.2 Collagen-based sealants 103
7.5.1.1.3 Gelatin-based sealants 104
7.5.1.1.4 Albumin-based sealants 106
7.5.1.1.5 Other natural/biological sealants 107
7.5.1.2 Natural/Biological sealants and adhesives, by origin 109
7.5.1.2.1 Human blood-based sealants and adhesives 109
7.5.1.2.2 Animal-based sealants and adhesives 110
7.5.2 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS AND ADHESIVES 111
7.5.2.1 Peg hydrogels 113
7.5.2.2 Cyanoacrylate-based sealants and adhesives 115
7.5.2.3 Urethane-based sealants and adhesives 117
7.5.2.4 Other synthetic and semi-synthetic sealants and adhesives 118
7.6 ADHESION BARRIERS 120
7.6.1 SYNTHETIC ADHESION BARRIERS 121
7.6.1.1 Hyaluronic acid-based adhesion barriers 123
7.6.1.2 Regenerated cellulose-based adhesion barriers 124
7.6.1.3 Peg-based adhesion barriers 126
7.6.1.4 Ther synthetic adhesion barriers 127
7.6.2 NATURAL ADHESION BARRIERS 128
7.6.2.1 Collagen & protein adhesion barriers 129
7.6.2.2 Fibrin-based adhesion barriers 131
7.7 STAPLE-LINE REINFORCEMENT AGENTS 132

8 BIOSURGERY MARKET, BY APPLICATION 134

8.1 INTRODUCTION 135
8.2 ORTHOPEDIC SURGERY 136
8.3 GENERAL SURGERY 137
8.4 NEUROLOGICAL SURGERY 138
8.5 CARDIOVASCULAR SURGERY 140
8.6 RECONSTRUCTIVE SURGERY 141
8.7 GYNECOLOGICAL SURGERY 142
8.8 UROLOGICAL SURGERY 144
8.9 THORACIC SURGERY 145

9 BIOSURGERY MARKET, BY REGION 147

9.1 INTRODUCTION 148
9.2 NORTH AMERICA 149
9.2.1 US 155
9.2.2 CANADA 160
9.3 EUROPE 165
9.3.1 GERMANY 172
9.3.2 UK 176
9.3.3 FRANCE 181
9.3.4 ITALY 186
9.3.5 SPAIN 191
9.3.6 REST OF EUROPE (ROE) 196
9.4 ASIA PACIFIC 201
9.4.1 JAPAN 207
9.4.2 CHINA 212
9.4.3 INDIA 217
9.4.4 REST OF ASIA PACIFIC 222
9.5 LATIN AMERICA 226
9.5.1 BRAZIL 231
9.5.2 MEXICO 236
9.5.3 REST OF LATIN AMERICA 242
9.6 MIDDLE EAST AND AFRICA 246

10 COMPETITIVE LANDSCAPE 252

10.1 OVERVIEW 252
10.2 MARKET SHARE ANALYSIS 253
10.2.1 SURGICAL SEALANTS AND ADHESIVES 253
10.2.2 HEMOSTATIC AGENTS 255
10.2.3 BONE-GRAFT SUBSTITUTES 256
10.2.4 ADHESION BARRIERS 257
10.2.5 SOFT-TISSUE ATTACHMENTS 258
10.3 COMPETITIVE SITUATIONS AND TRENDS 259
10.3.1 PRODUCT LAUNCHES AND APPROVALS 259
10.3.2 AGREEMENTS AND PARTNERSHIPS 260
10.3.3 ACQUISITIONS 261
10.3.4 EXPANSIONS 262

11 COMPANY PROFILES 263

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View)*
11.1 BAXTER INTERNATIONAL, INC. 263
11.2 B.BRAUN MELSUNGEN AG 267
11.3 C.R. BARD 270
11.4 JOHNSON & JOHNSON 273
11.5 MEDTRONIC, PLC. 277
11.6 MAQUET HOLDING B.V. & CO. KG. (GETINGE GROUP) 281
11.7 COHERA MEDICAL INC. 284
11.8 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 286
11.9 COMMONWEALTH SERUM LABORATORIES (CSL) 290
11.10 HEMOSTASIS, LLC 292
11.11 SANOFI 293
11.12 PFIZER INC. 295
11.13 STRYKER CORPORATION 297
11.14 CRYOLIFE, INC. 300
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View might not be captured in case of unlisted companies.
12 APPENDIX 303

LIST OF TABLES

TABLE 1 STANDARD CURRENCY CONVERSION RATES 29
TABLE 2 BIOSURGERY MARKET SNAPSHOT 40
TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS 51
TABLE 4 PERCENTAGE INCREASE IN THE NUMBER OF SURGICAL PROCEDURES PERFORMED IN THE US 53
TABLE 5 MAJOR ACQUISITIONS IN THE BIOSURGERY MARKET (2015–2017) 58
TABLE 6 NUMBER OF PRODUCT LAUNCHES BY KEY PLAYERS (2015–2018) 59
TABLE 7 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES 61
TABLE 8 STRINGENCY OF REGULATIONS FOR BIOSURGERY PRODUCTS, BY COUNTRY 61
TABLE 9 BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 75
TABLE 10 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE,
2016–2023 (USD MILLION) 77
TABLE 11 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY COUNTRY,
2016–2023 (USD MILLION) 77
TABLE 12 MAJOR PRODUCTS IN THE DBM MARKET 78
TABLE 13 DEMINERALIZED BONE MATRIX MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 80
TABLE 14 MAJOR PRODUCTS IN THE SYNTHETIC BONE GRAFTS MARKET 81
TABLE 15 SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 82
TABLE 16 MAJOR PRODUCTS IN THE BONE MORPHOGENETIC PROTEINS MARKET 83
TABLE 17 BONE MORPHOGENETIC PROTEINS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 83
TABLE 18 MAJOR PRODUCTS IN THE OTHER BONE-GRAFT SUBSTITUTES MARKET 84
TABLE 19 OTHER BONE-GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 85
TABLE 20 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE,
2016-2023 (USD MILLION) 86
TABLE 21 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY COUNTRY,
2016-2023 (USD MILLION) 87
TABLE 22 MAJOR PRODUCTS IN THE SYNTHETIC MESHES MARKET 88
TABLE 23 SYNTHETIC MESHES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 89
TABLE 24 BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 90
TABLE 25 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 90
TABLE 26 ALLOGRAFTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 91
TABLE 27 XENOGRAFTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 92
TABLE 28 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE,
2016-2023 (USD MILLION) 93
TABLE 29 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY COUNTRY,
2016-2023 (USD MILLION) 94
TABLE 30 MAJOR PRODUCTS IN THE THROMBIN-BASED HEMOSTATIC AGENTS MARKET 95
TABLE 31 THROMBIN-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 95
TABLE 32 MAJOR PRODUCTS IN THE OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET 96
TABLE 33 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET,
BY COUNTRY, 2016-2023 (USD MILLION) 96
TABLE 34 MAJOR PRODUCTS IN THE COMBINATION HEMOSTATIC AGENTS 97
TABLE 35 COMBINATION HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 97
TABLE 36 BIOSURGERY MARKET FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE,
2016-2023 (USD MILLION) 99
TABLE 37 BIOSURGERY MARKET FOR SURGICAL SEALANTS AND ADHESIVES MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 38 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES,
BY TYPE, 2016–2023 (USD MILLION) 100
TABLE 39 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES,
BY COUNTRY, 2016–2023 (USD MILLION) 101
TABLE 40 MAJOR PRODUCTS IN THE FIBRIN SEALANTS MARKET 102
TABLE 41 FIBRIN SEALANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 102
TABLE 42 MAJOR PRODUCTS IN THE COLLAGEN BASED-SEALANTS MARKET 103
TABLE 43 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 104
TABLE 44 MAJOR PRODUCTS IN THE GELATIN BASED-SEALANTS MARKET 105
TABLE 45 GELATIN-BASED SEALANTS MARKET , BY COUNTRY, 2016–2023 (USD MILLION) 105
TABLE 46 MAJOR PRODUCTS IN THE ALBUMIN BASED-SEALANTS MARKET 106
TABLE 47 ALBUMIN-BASED SEALANTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 107
TABLE 48 OTHER NATURAL/BIOLOGICAL SEALANTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 108
TABLE 49 NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN,
2016-2023 (USD MILLION) 109
TABLE 50 HUMAN BLOOD-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 110
TABLE 51 ANIMAL-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 111
TABLE 52 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 112
TABLE 53 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS AND ADHESIVES MARKET,
BY COUNTRY, 2016-2023 (USD MILLION) 113
TABLE 54 MAJOR PRODUCTS IN THE PEG HYDROGEL-BASED SEALANTS AND ADHESIVES MARKET 114
TABLE 55 PEG HYDROGEL-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 115
TABLE 56 MAJOR PRODUCTS IN THE CYANOACRYLATE-BASED SEALANTS AND ADHESIVES MARKET 116
TABLE 57 CYANOACRYLATE-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 117
TABLE 58 MAJOR URETHANE-BASED SEALANTS AND ADHESIVES IN THE MARKET 118
TABLE 59 URETHANE-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 118
TABLE 60 OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS AND ADHESIVES MARKET,
BY COUNTRY, 2016-2023 (USD MILLION) 119
TABLE 61 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE,
2016-2023 (USD MILLION) 120
TABLE 62 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY COUNTRY,
2016-2023 (USD MILLION) 121
TABLE 63 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 122
TABLE 64 SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 122
TABLE 65 MAJOR PRODUCTS IN THE HYALURONIC ACID-BASED ADHESION BARRIERS MARKET 123
TABLE 66 HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 124
TABLE 67 MAJOR PRODUCTS IN THE REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET 125
TABLE 68 REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 125
TABLE 69 MAJOR PRODUCTS IN THE PEG-BASED ADHESION BARRIERS MARKET 126
TABLE 70 PEG-BASED ADHESION BARRIERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 126
TABLE 71 MAJOR PRODUCTS IN THE OTHER SYNTHETIC ADHESION BARRIERS MARKET 127
TABLE 72 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 128
TABLE 73 NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 74 NATURAL ADHESION BARRIERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 129
TABLE 75 MAJOR PRODUCTS IN THE COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET 130
TABLE 76 COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 130
TABLE 77 MAJOR PRODUCTS IN THE FIBRIN-BASED ADHESION BARRIERS MARKET 131
TABLE 78 FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 131
TABLE 79 MAJOR PRODUCTS IN THE STAPLE-LINE REINFORCEMENT AGENTS MARKET 132
TABLE 80 BIOSURGERY MARKET FOR STAPLE-LINE REINFORCEMENT AGENTS, BY COUNTRY, 2016–2023 (USD MILLION) 133
TABLE 81 BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 135
TABLE 82 ORTHOPEDIC SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 137
TABLE 83 GENERAL SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 138
TABLE 84 NEUROLOGICAL SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 139
TABLE 85 CARDIOVASCULAR SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 140
TABLE 86 RECONSTRUCTIVE SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 142
TABLE 87 COUNTRIES WITH THE HIGHEST C-SECTION RATE (2015) 143
TABLE 88 GYNECOLOGICAL SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 144
TABLE 89 UROLOGICAL SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 145
TABLE 90 THORACIC SURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 146
TABLE 91 BIOSURGERY MARKET, BY REGION, 2016–2023 (USD MILLION) 149
TABLE 92 NORTH AMERICA: BIOSURGERY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 151
TABLE 93 NORTH AMERICA: BIOSURGERY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 151
TABLE 94 NORTH AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 151
TABLE 95 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 152
TABLE 96 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 152
TABLE 97 NORTH AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 152
TABLE 98 NORTH AMERICA: ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 153
TABLE 99 NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 153
TABLE 100 NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 153
TABLE 101 NORTH AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 154
TABLE 102 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2016–2023 (USD MILLION) 154
TABLE 103 NORTH AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 154
TABLE 104 NORTH AMERICA: BIOSURGERY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 155
TABLE 105 US: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 156
TABLE 106 US: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 156
TABLE 107 US: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 156
TABLE 108 US: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 157
TABLE 109 US: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 157
TABLE 110 US: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 157
TABLE 111 US: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 158
TABLE 112 US: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 158
TABLE 113 US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 158
TABLE 114 US: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 159
TABLE 115 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 159
TABLE 116 US: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 159
TABLE 117 US: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 160
TABLE 118 CANADA: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 161
TABLE 119 CANADA: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 161
TABLE 120 CANADA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 161
TABLE 121 CANADA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 162
TABLE 122 CANADA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 162
TABLE 123 CANADA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 162
TABLE 124 CANADA: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 163
TABLE 125 CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 163
TABLE 126 CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 163
TABLE 127 CANADA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 164
TABLE 128 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 164
TABLE 129 CANADA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 164
TABLE 130 CANADA: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 165
TABLE 131 EUROPE: BIOSURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 167
TABLE 132 EUROPE: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 167
TABLE 133 EUROPE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 167
TABLE 134 EUROPE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 168
TABLE 135 EUROPE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 168
TABLE 136 EUROPE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 169
TABLE 137 EUROPE: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 169
TABLE 138 EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 169
TABLE 139 EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 170
TABLE 140 EUROPE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 170
TABLE 141 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 170
TABLE 142 EUROPE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 171
TABLE 143 EUROPE: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 171
TABLE 144 GERMANY: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 172
TABLE 145 GERMANY: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 172
TABLE 146 GERMANY: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 173
TABLE 147 GERMANY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 173
TABLE 148 GERMANY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 173
TABLE 149 GERMANY: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 174
TABLE 150 GERMANY: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 174
TABLE 151 GERMANY: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 174
TABLE 152 GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 175
TABLE 153 GERMANY: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 175
TABLE 154 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 175
TABLE 155 GERMANY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 176
TABLE 156 GERMANY: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 176
TABLE 157 UK: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 177
TABLE 158 UK: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 177
TABLE 159 UK: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 178
TABLE 160 UK: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 178
TABLE 161 UK: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 178
TABLE 162 UK: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 163 UK: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 179
TABLE 164 UK: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 179
TABLE 165 UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 180
TABLE 166 UK: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 167 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 168 UK: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 181
TABLE 169 UK: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 181
TABLE 170 FRANCE: KEY MACROINDICATORS FOR THE BOSURGERY MARKET 182
TABLE 171 FRANCE: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 182
TABLE 172 FRANCE: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 183
TABLE 173 FRANCE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 183
TABLE 174 FRANCE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 183
TABLE 175 FRANCE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 184
TABLE 176 FRANCE: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 184
TABLE 177 FRANCE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 184
TABLE 178 FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 185
TABLE 179 FRANCE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 185
TABLE 180 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 185
TABLE 181 FRANCE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 186
TABLE 182 FRANCE: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 186
TABLE 183 ITALY: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 187
TABLE 184 ITALY: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 187
TABLE 185 ITALY: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 187
TABLE 186 ITALY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 188
TABLE 187 ITALY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 188
TABLE 188 ITALY: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 188
TABLE 189 ITALY: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 189
TABLE 190 ITALY: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 189
TABLE 191 ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 189
TABLE 192 ITALY: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 190
TABLE 193 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 190
TABLE 194 ITALY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 190
TABLE 195 ITALY: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 191
TABLE 196 SPAIN: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 192
TABLE 197 SPAIN: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 192
TABLE 198 SPAIN: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 192
TABLE 199 SPAIN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 193
TABLE 200 SPAIN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 193
TABLE 201 SPAIN: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 194
TABLE 202 SPAIN: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 194
TABLE 203 SPAIN: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 194
TABLE 204 SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 195
TABLE 205 SPAIN: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 195
TABLE 206 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 195
TABLE 207 SPAIN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 196
TABLE 208 SPAIN: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 196
TABLE 209 ROE: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 197
TABLE 210 ROE: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 197
TABLE 211 ROE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 198
TABLE 212 ROE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 198
TABLE 213 ROE: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 198
TABLE 214 ROE: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 199
TABLE 215 ROE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 199
TABLE 216 ROE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 199
TABLE 217 ROE: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 200
TABLE 218 ROE: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 200
TABLE 219 ROE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 200
TABLE 220 ROE: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 201
TABLE 221 APAC: BIOSURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 202
TABLE 222 APAC: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 203
TABLE 223 APAC: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 203
TABLE 224 APAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 204
TABLE 225 APAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 204
TABLE 226 APAC: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 204
TABLE 227 APAC: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 205
TABLE 228 APAC: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 205
TABLE 229 APAC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 205
TABLE 230 APAC: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 206
TABLE 231 APAC: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 206
TABLE 232 APAC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 206
TABLE 233 APAC: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 207
TABLE 234 JAPAN: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 208
TABLE 235 JAPAN: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 208
TABLE 236 JAPAN: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 208
TABLE 237 JAPAN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 209
TABLE 238 JAPAN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 209
TABLE 239 JAPAN: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 209
TABLE 240 JAPAN: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 210
TABLE 241 JAPAN: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 210
TABLE 242 JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 210
TABLE 243 JAPAN: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 211
TABLE 244 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 211
TABLE 245 JAPAN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 211
TABLE 246 JAPAN: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 212
TABLE 247 CHINA: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 213
TABLE 248 CHINA: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 213
TABLE 249 CHINA: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 213
TABLE 250 CHINA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 214
TABLE 251 CHINA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 214
TABLE 252 CHINA: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 214
TABLE 253 CHINA: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 215
TABLE 254 CHINA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 215
TABLE 255 CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 215
TABLE 256 CHINA: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016–2023 (USD MILLION) 216
TABLE 257 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 216
TABLE 258 CHINA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 216
TABLE 259 CHINA: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 217
TABLE 260 INDIA: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 217
TABLE 261 INDIA: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 218
TABLE 262 INDIA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 218
TABLE 263 INDIA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 218
TABLE 264 INDIA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 219
TABLE 265 INDIA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 219
TABLE 266 INDIA: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 219
TABLE 267 INDIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 220
TABLE 268 INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 220
TABLE 269 INDIA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 220
TABLE 270 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 221
TABLE 271 INDIA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 221
TABLE 272 INDIA: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 221
TABLE 273 ROAPAC: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 222
TABLE 274 ROAPAC: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 223
TABLE 275 ROAPAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 223
TABLE 276 ROAPAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 223
TABLE 277 ROAPAC: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 224
TABLE 278 ROAPAC: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 224
TABLE 279 ROAPAC: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 224
TABLE 280 ROAPAC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 225
TABLE 281 ROAPAC: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 225
TABLE 282 ROAPAC: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 225
TABLE 283 ROAPAC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 226
TABLE 284 ROAPAC: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 226
TABLE 285 LATIN AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 227
TABLE 286 LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 227
TABLE 287 LATIN AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 228
TABLE 288 LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 228
TABLE 289 LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 228
TABLE 290 LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 229
TABLE 291 LATIN AMERICA: ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 229
TABLE 292 LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 229
TABLE 293 LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 230
TABLE 294 LATIN AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 230
TABLE 295 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2016–2023 (USD MILLION) 230
TABLE 296 LATIN AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 231
TABLE 297 LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 231
TABLE 298 BRAZIL: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 232
TABLE 299 BRAZIL: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 232
TABLE 300 BRAZIL: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 233
TABLE 301 BRAZIL: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 233
TABLE 302 BRAZIL: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 233
TABLE 303 BRAZIL: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 234
TABLE 304 BRAZIL: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 234
TABLE 305 BRAZIL: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 234
TABLE 306 BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 235
TABLE 307 BRAZIL: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 235
TABLE 308 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 235
TABLE 309 BRAZIL: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 236
TABLE 310 BRAZIL: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 236
TABLE 311 MEXICO: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET 237
TABLE 312 MEXICO: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 237
TABLE 313 MEXICO: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 237
TABLE 314 MEXICO: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 238
TABLE 315 MEXICO: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 238
TABLE 316 MEXICO: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 239
TABLE 317 MEXICO: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 239
TABLE 318 MEXICO: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 239
TABLE 319 MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 240
TABLE 320 MEXICO: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 240
TABLE 321 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 240
TABLE 322 MEXICO: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 241
TABLE 323 MEXICO: BIOSURGERY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 241
TABLE 324 ROLA: BIOSURGERY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 242
TABLE 325 ROLA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2016–2023 (USD MILLION) 242
TABLE 326 ROLA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 243
TABLE 327 ROLA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN,
2016–2023 (USD MILLION) 243
TABLE 328 ROLA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 243
TABLE 329 ROLA: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 244
TABLE 330 ROLA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 244
TABLE 331 ROLA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 244
TABLE 332 ROLA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 245
TABLE 333 ROLA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016–2023 (USD MILLION) 245
TABLE 334 ROLA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016–2023 (USD MILLION) 245
TABLE 335 REST OF LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 246
TABLE 336 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 247
TABLE 337 MIDDLE EAST AND AFRICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016–2023 (USD MILLION) 247
TABLE 338 MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 247
TABLE 339 MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016–2023 (USD MILLION) 248
TABLE 340 MIDDLE EAST AND AFRICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 248
TABLE 341 MIDDLE EAST AND AFRICA: ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 248
TABLE 342 MIDDLE EAST AND AFRICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 249
TABLE 343 MIDDLE EAST AND AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 249
TABLE 344 MIDDLE EAST AND AFRICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 249
TABLE 345 MIDDLE EAST AND AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2016–2023 (USD MILLION) 250
TABLE 346 MIDDLE EAST AND AFRICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2016–2023 (USD MILLION) 250
TABLE 347 MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 251
TABLE 348 GROWTH STRATEGY MATRIX (2015–2018) 253
TABLE 349 PRODUCT LAUNCHES, 2015–2018 259
TABLE 350 AGREEMENTS AND PARTNERSHIPS, 2015-2018 260
TABLE 351 ACQUISITIONS, 2015-2018 261
TABLE 352 EXPANSIONS, 2015-2018 262

LIST OF FIGURES

FIGURE 1 BIOSURGERY MARKET 27
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 PRIMARY SOURCES 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 35
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION 36
FIGURE 6 DATA TRIANGULATION METHODOLOGY 38
FIGURE 7 BIOSURGERY MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 41
FIGURE 8 NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE,
2018 VS. 2023 (USD MILLION) 41
FIGURE 9 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE,
2018 VS. 2023 (USD MILLION) 42
FIGURE 10 HEMOSTATS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 42
FIGURE 11 SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 43
FIGURE 12 ADHESION BARRIER MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 43
FIGURE 13 SYNTHETIC ADHESION BARRIER MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 44
FIGURE 14 BONE-GRAFT SUBSTITUTE MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 44
FIGURE 15 BIOSURGERY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 45
FIGURE 16 BIOSURGERY MARKET SHARE, BY REGION 46
FIGURE 17 INCREASE IN THE VOLUME OF SURGERIES TO DRIVE MARKET GROWTH 47
FIGURE 18 BONE-GRAFT SUBSTITUTES HELD THE LARGEST SHARE OF THE APAC MARKET
IN 2017 48
FIGURE 19 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE BIOSURGERY MARKET
IN 2017 49
FIGURE 20 APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 50
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD 50
FIGURE 22 GROWTH IN GERIATRIC POPULATION, BY REGION, 2015–2050 52
FIGURE 23 INCREASING MARKET CONSOLIDATION & RISING FOCUS ON PRODUCT DEVELOPMENTS ARE THE MAJOR TRENDS IN THE BIOSURGERY MARKET 57
FIGURE 24 PRODUCT LAUNCHES AND APPROVALS — KEY GROWTH STRATEGY ADOPTED BY MAJOR PLAYERS IN THE BIOSURGERY MARKET (2015–2018) 58
FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 63
FIGURE 26 BIOSURGERY MARKET: VENDOR BENCHMARKING 68
FIGURE 27 BONE-GRAFT SUBSTITUTES SEGMENT TO DOMINATE THE BIOSURGERY MARKET
IN 2018 75
FIGURE 28 DEMINERALIZED BONE MATRIX SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 76
FIGURE 29 SYNTHETIC MESHES SEGMENT TO GROW AT THE HIGHEST CAGR 86
FIGURE 30 COMBINATION HEMOSTATS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 93
FIGURE 31 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 98
FIGURE 32 HUMAN BLOOD-BASED SEALANTS AND ADHESIVES TO DOMINATE THE NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET 109
FIGURE 33 SYNTHETIC ADHESION BARRIERS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 120
FIGURE 34 ORTHOPEDIC SURGERY TO DOMINATE THE BIOSURGERY APPLICATIONS MARKET DURING THE FORECAST PERIOD 135
FIGURE 35 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS 148
FIGURE 36 NORTH AMERICA: BIOSURGERY MARKET SNAPSHOT 150
FIGURE 37 EUROPE: BIOSURGERY MARKET SNAPSHOT 166
FIGURE 38 APAC: BIOSURGERY MARKET SNAPSHOT 202
FIGURE 39 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2015 AND
MARCH 2018 252
FIGURE 40 SURGICAL SEALANTS AND ADHESIVES MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2017 254
FIGURE 41 HEMOSTATIC AGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 255
FIGURE 42 BONE-GRAFT SUBSTITUTES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 256
FIGURE 43 ADHESION BARRIERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 257
FIGURE 44 SOFT-TISSUE ATTACHMENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 258
FIGURE 45 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2017) 264
FIGURE 46 B.BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2017) 267
FIGURE 47 C.R. BARD: COMPANY SNAPSHOT (2016) 270
FIGURE 48 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2017) 273
FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2017) 277
FIGURE 50 GETINGE GROUP: COMPANY SNAPSHOT (2017) 281
FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2017) 286
FIGURE 52 COMMONWEALTH SERUM LABORATORIES: COMPANY SNAPSHOT (2017) 290
FIGURE 53 SANOFI: COMPANY SNAPSHOT (2017) 293
FIGURE 54 PFIZER INC.: COMPANY SNAPSHOT (2017) 295
FIGURE 55 STRYKER CORPORATION: COMPANY SNAPSHOT (2017) 297
FIGURE 56 CRYOLIFE: COMPANY SNAPSHOT (2017) 300

当レポートのプレスリリースは発行されておりません。